new drugs

  • January 31, 2007  

    The Food and Drug Administration announced it is making more than a dozen changes to improve oversight of prescription drugs, including increased monitoring of drugs’ safety after they are on the market. FDA Commissioner Dr. Andrew Von Eschenbach discusses the changes. Continue reading